(Photo by RHJPhtotos on Shutterstock)
In a nutshell
- Creatine monohydrate is as safe as taking a placebo, with only 4.6% of users reporting any side effects compared to 4.2% of placebo users
- Analysis of 685 studies involving over 26,000 participants found no evidence that creatine causes kidney damage, muscle cramps, or other commonly feared side effects
- Government adverse event databases show creatine appears in just 0.00072% of all reported problems, with nearly half of those reports involving products that contained no creatine at all
COLLEGE STATION, Texas — For decades, gym-goers have whispered warnings about creatine: It’ll damage your kidneys. It causes muscle cramps. It leads to dehydration. But the largest safety analysis ever conducted on this wildly popular supplement has just delivered a verdict that might surprise millions of fitness enthusiasts — and their worried parents.
After analyzing data from 685 clinical trials involving over 26,000 participants, researchers found that creatine monohydrate is no more likely to cause side effects than a sugar pill. The comprehensive study, published in the Journal of the International Society of Sports Nutrition, examined everything from gastrointestinal issues to kidney function across studies lasting up to 14 years.
Only 4.6% of people taking creatine reported any side effects at all compared to 4.2% of those taking placebos. The difference was so small it could be due to chance alone.
Long-Standing Creatine Fears Prove Unfounded
The study directly challenged some of the most persistent concerns surrounding creatine use. Take muscle cramping, for instance, a fear that has kept many athletes away from the supplement. While slightly more studies reported cramping in creatine users (2.9%) compared to placebo groups (0.9%), when researchers looked at the actual number of participants affected, the difference vanished. Only 0.52% of creatine users experienced cramping versus 0.07% of placebo users, a statistically insignificant difference.
Similarly, gastrointestinal issues showed no meaningful difference between groups when examining individual participants rather than just counting studies. Perhaps most importantly for long-term users, the analysis found no evidence that creatine damages kidney function, a fear that has persisted despite decades of research.
Beyond clinical trials, researchers also analyzed adverse event reports from government databases across five countries, covering 28.4 million reports spanning up to 50 years. Creatine appeared in just 203 of these reports, a microscopic 0.00072% of all adverse events tracked.

Health Benefits Extend Far Beyond the Gym
These safety findings become particularly relevant given creatine’s expanding role beyond athletics. Recent research has shown the supplement may benefit brain health, help manage depression, and support healthy aging. It’s being studied as a potential treatment for conditions ranging from Parkinson’s disease to traumatic brain injury.
The body naturally produces about half the creatine it needs, with the rest typically coming from meat and fish. But many people, particularly vegetarians, older adults, and those following plant-based diets may not get enough from food alone. Low dietary creatine intake has been linked to various health problems, from reduced cognitive function in older adults to increased risk of depression.
For children and adolescents, the safety findings are especially relevant. Analysis of government nutrition data has shown that kids with low dietary creatine intake tend to be shorter, weigh less, and have less lean muscle mass than those getting adequate amounts. Yet fears about supplement safety have led some schools and sports organizations to ban creatine use entirely.
Social Media Spreads Unfounded Creatine Fears
To gauge public perception, researchers analyzed social media sentiment, examining over 129,000 YouTube comments and 657,000 tweets. While overall sentiment was neutral, they found that negative perceptions often stemmed from companies promoting alternative forms of creatine by spreading unfounded fears about the standard, well-researched creatine monohydrate.
Even more telling, 46% of U.S. reports that mentioned creatine actually involved products that contained no creatine at all when researchers checked the ingredient lists. Many of the remaining reports involved people taking creatine alongside other supplements or medications, making it impossible to blame creatine alone for any problems.
Dr. Richard Kreider, the study’s lead author and a professor at Texas A&M University, has spent decades researching creatine safety. His team’s exhaustive analysis represents the most comprehensive safety review ever conducted on any dietary supplement. The research examined 35 different types of potential side effects, from common complaints like nausea and headaches to serious concerns about liver and kidney function. Across every category, creatine users fared no worse than those taking placebos.
Ninety-five percent of the studies used creatine monohydrate, the most researched and widely available form. The supplement industry is flooded with newer, more expensive variants that claim superior benefits or fewer side effects, despite lacking the extensive safety data backing creatine monohydrate.
These findings have practical implications for millions of supplement users and the healthcare providers who advise them. The research shows that common warnings about creatine, often based on isolated case reports or theoretical concerns, may be doing more harm than good by discouraging use of a beneficial supplement.
For athletes, the results provide reassurance that creatine won’t increase injury risk or cause the dehydration and cramping often attributed to it. For older adults exploring ways to maintain muscle mass and cognitive function, the data shows creatine supplementation can be undertaken safely even with long-term use.
After examining the most comprehensive dataset ever assembled on creatine safety, encompassing hundreds of studies, millions of adverse event reports, and years of social media discourse, the verdict is clear: creatine monohydrate is remarkably safe. The supplement that millions use to boost their workouts poses no greater risk of side effects than taking nothing at all, even when used for years at a time. For a fitness world often plagued by supplement scares and safety concerns, this research delivers much-needed clarity.
Paper Summary
Methodology
Researchers conducted a comprehensive analysis examining creatine safety from multiple angles. They reviewed 685 clinical trials involving 26,291 participants across studies lasting up to 14 years. The team also analyzed 28.4 million adverse event reports from government databases in the United States, Canada, Australia, Europe, and other countries spanning 10-50 years of monitoring. Additionally, they performed sentiment analysis on over 129,000 YouTube comments and 657,000 tweets to gauge public perceptions about creatine safety.
Results
Only 13.7% of studies reported any side effects in creatine groups compared to 13.2% in placebo groups—a statistically insignificant difference. When examining individual participants rather than just study counts, 4.6% of creatine users reported side effects versus 4.2% of placebo users. No significant differences were found for any of the 35 side effects categories examined, including kidney function markers, gastrointestinal issues, and muscle cramping. Creatine appeared in just 0.00072% of adverse event reports worldwide, with nearly half of U.S. reports incorrectly attributing problems to products that contained no creatine.
Limitations
The analysis was limited to information provided in published studies, and some research papers may not have fully detailed all side effects or participant demographics. Adverse event reports don’t establish causality and often involved multiple supplements or medications. The social media analysis had time restrictions and may not capture all relevant platforms or conversations about creatine safety.
Funding and Disclosures
The study was supported by the Exercise and Sports Nutrition Lab at Texas A&M University. Publication costs were funded by Alzchem Group AG as part of a special conference issue. Lead author Dr. Kreider disclosed relationships with companies involved in creatine research and serves on scientific advisory boards, though he has no ownership in supplement companies or patents related to creatine.
Publication Information
The study “Safety of creatine supplementation: analysis of the prevalence of reported side effects in clinical trials and adverse event reports” was published in the Journal of the International Society of Sports Nutrition, Volume 22, 2025, by Richard B. Kreider, Drew E. Gonzalez, Kelly Hines, Adriana Gil, and Diego A. Bonilla.







